
Roche repeats at No. 1 position; AbbVie vaults five spots
Roche repeats at No. 1 position; AbbVie vaults five spots
Acquisition to expand presence in genomic medicine
Aims to enhance company's mRNA and viral vector capabilities
Horizon Therapeutics to purchase production facility from Irish specialty care company
How emerging life sciences organizations can create value with suppliers
How the pharma serialization and track-and-trace sector can be better prepared, should the world be unlucky enough to experience another global crisis
Health insurer Anthem joins BCBS organizations to form CivicaScript
Project SKY features one of Europe’s largest facilities for advanced therapies, says CDMO
Via remote data capture, alliance aids outcomes data collection for patients undergoing treatment
Will help UK consortium advance oral solid dosage medicines production
CDMO's Germany facility will supply starting material as part of manufacturing deal
Acquisition of Walgreens Boots Alliance's wholesaling business extends ABC’s pharma manufacturing and distribution reach
Merger with Oblikue Consulting gives specialist provider greater European and LATAM exposure for pricing and reimbursement
Will support pharma manufacturers with digital health and commercialization services
Company unifies its patient support services
Collaboration to focus on merging data with machine learning to make healthcare content more accessible
Pact between CPI and Cambridge Design Partnership aims to streamline the innovation-to-commercialization journey
Facility will house 44,000 square feet of clinical and commercial cGMP, and other tech services
Third deal in two months for the CRO expands capabilities in cell and gene therapy
Pharma and nutraceuticals collaborate, as deal introduces logistics program to Bonne Santé Group
Research report: 41% of US cannabis consumers self-identify as medical consumers
Portrix acquisition strengthens company’s supply chain presence
Will use new facility in Belgium for commercial production of plasmid DNA
The drive for “vaccine equity” around the world is strengthening efforts to limit patent protections on innovative drugs and vaccines to combat Covid
Purchase of technology-powered CRO grows Aixial's offerings in clinical operations and product development